| http://www.w3.org/ns/prov#value | - The present inventors show that endotoxin and other sensitizing agents are able to further increase the procoagulant activity of tumor endothelium, rendering tumor vasculature more sensitive to thrombosis induction by coagulant-based tumor therapeutics, such as tTF and coaguligands, and that this can be achieved without upsetting the balance in normal blood vessels, and without causing thrombosis
|
